Cover Image
市場調查報告書

病毒清除的全球市場預測 ∼2020年:各用途 (幹細胞、血液、組織、細胞、基因治療)、手法 (惰性化、消除、PCR、ELISA)、終端用戶

Viral Clearance Market by Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Inactivation, Removal (Precipitation), Detection (PCR, ELISA)) & End User (Pharmaceutical & Biotechnology, CROs, Research Institute) - Global Forecast to 2020

出版商 MarketsandMarkets 商品編碼 355925
出版日期 內容資訊 英文 166 Pages
訂單完成後即時交付
價格
Back to Top
病毒清除的全球市場預測 ∼2020年:各用途 (幹細胞、血液、組織、細胞、基因治療)、手法 (惰性化、消除、PCR、ELISA)、終端用戶 Viral Clearance Market by Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Inactivation, Removal (Precipitation), Detection (PCR, ELISA)) & End User (Pharmaceutical & Biotechnology, CROs, Research Institute) - Global Forecast to 2020
出版日期: 2016年04月04日 內容資訊: 英文 166 Pages
簡介

全球病毒清除的市場預計從2015年到2020年以12.3%的年複合成長率發展,從2015年的2億8550萬美元,成長到2020年5億1030萬美元的規模。在醫藥品及生物科技產業的利用的擴大和新藥的上市數量的增加等成為該市場的主要推進因素。

本報告提供全球病毒清除的市場調查,市場定義和概要,對市場成長的各種影響因素與課題,各用途、手法、終端用戶、地區的趨勢與市場規模的變化與預測,競爭環境,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 市場概要
  • 生命週期分析:各地區

第5章 市場概要

  • 簡介
  • 市場動態
    • 成長推進因素
    • 阻礙成長要素
    • 機會
    • 課題

第6章 市場分析:各用途

  • 簡介
  • 疫苗、治療藥
  • 血液、血液產品
  • 細胞、基因治療產品
  • 組織、組織產品
  • 幹細胞產品

第7章 市場分析:各終端用戶

  • 簡介
  • 醫藥品、生物科技企業
  • CRO
  • 學術、研究機關
  • 其他

第8章 市場分析:各手法

  • 簡介
  • 病毒檢測法
    • 斑塊檢測法
    • PCR
    • ELISA
    • 其他
  • 病毒消除
    • 層析法
    • 奈米過濾
    • 沉澱
  • 病毒不活化
    • 界面活性劑處理
    • 低溫殺菌
    • 其他

第9章 地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
  • 亞洲
  • 其他地區

第10章 競爭環境

  • 概要
  • 主要企業
  • 競爭情形、趨勢
    • 擴張
    • 協定、聯盟、合作
    • 收購
    • 服務投入

第11章 企業簡介

  • 簡介
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • LONZA GROUP
  • SIGMA-ALDRICH CORPORATION
  • SGS S.A.
  • WUXI PHARMATECH (CAYMAN) INC.
  • AVANCE BIOSCIENCES INC.
  • BSL BIOSERVICE
  • CLEAN CELLS INC.
  • MERCK KGAA
  • TEXCELL, INC.
    • 概要
    • 財務趨勢
    • 產品與服務
    • 策略
    • 發展趨勢等

第12章 附錄

圖表

目錄
Product Code: BT 4202

The global viral clearance market is projected to reach USD 510.3 million by 2020 from USD 285.5 million in 2015, at a CAGR of 12.3% from 2015 to 2020. The major drivers for the market include increase in pharmaceutical and biological industries and increasing number of new drug launches. Over the years, the number of drug approvals in North American countries has increased from 2006 to 2015. The increasing number of drug approvals will boost the viral clearance market.

This report segments the global viral clearance market is segmented based on method, end user, application, and geography. The method segments included in the report are viral detection method, viral removal method, and viral inactivation method. The viral detection method is further subsegmented in to plaque assays, PCR, ELISA, and other viral detection method. Other viral detection method includes western blot, transmission EM, in vivo assay, in vitro assay, and NGS (Next Generation Sequencing). The viral removal method is further subsegmented in to chromatography, nanofiltration, and precipitation. The viral inactivation method is further subsegmented in to solvent detergent method, pasteurization, and other viral inactivation method. Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light.

The application segments included in the report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics.

Based on end user this market is categorized into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users. Other end user segment primarily includes medical device companies, cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.

The geographic segments included in this report are Asia, Europe, North America and the Rest of the World (RoW). North America is further divided into Canada and the U.S.

The report provides qualitative insights on key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised to see rapid growth. The report also includes company profiles of market leaders. These company profiles include the financial performances, product portfolios, and developments of each company. The report also provides a competitive landscape of the viral clearance market. The competitive landscape covers the growth strategies adopted by industry players over the last three years. It also includes analyses of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:

  • Product Development/Innovation: Product portfolios of top players in the viral clearance market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the viral clearance market
  • Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of leading players in the viral clearance market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various viral clearance products across geographies
  • Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the viral clearance market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL VIRAL CLEARANCE MARKET OVERVIEW
  • 4.2. LIFE CYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
    • 5.1.1. MARKET SEGMENTATION, BY APPLICATION
    • 5.1.2. MARKET SEGMENTATION, BY END USER
    • 5.1.3. MARKET SEGMENTATION, BY METHOD
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rapid growth in pharmaceutical and biotechnology industries
      • 5.2.1.2. Increasing number of new drug launches
      • 5.2.1.3. Strong trend of R&D investments in the life sciences industry
      • 5.2.1.4. Increasing government support for pharmaceutical and biotechnology industries
      • 5.2.1.5. High incidence and large economic burden of chronic diseases
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High degree of consolidation to act as a major barrier for new entrants
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Increasing pharmaceutical outsourcing
      • 5.2.3.2. Developing countries present significant opportunities for the viral clearance market
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Stringent regulatory frameworks and time-consuming approval processes

6. VIRAL CLEARANCE MARKET, BY APPLICATION

  • 6.1. INTRODUCTION
  • 6.2. VACCINES AND THERAPEUTICS
  • 6.3. BLOOD AND BLOOD PRODUCTS
  • 6.4. CELLULAR AND GENE THERAPY PRODUCTS
  • 6.5. TISSUE AND TISSUE PRODUCTS
  • 6.6. STEM CELL PRODUCTS

7. VIRAL CLEARANCE MARKET, BY END USER

  • 7.1. INTRODUCTION
  • 7.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 7.3. CONTRACT RESEARCH ORGANIZATIONS
  • 7.4. ACADEMIC RESEARCH INSTITUTES
  • 7.5. OTHER END USERS

8. VIRAL CLEARANCE MARKET, BY METHOD

  • 8.1. INTRODUCTION
  • 8.2. VIRAL DETECTION METHOD
    • 8.2.1. PLAQUE ASSAYS
    • 8.2.2. PCR
    • 8.2.3. ELISA
    • 8.2.4. OTHER VIRAL DETECTION METHODS
  • 8.3. VIRAL REMOVAL
    • 8.3.1. CHROMATOGRAPHY
    • 8.3.2. NANOFILTRATION
    • 8.3.3. PRECIPITATION
  • 8.4. VIRAL INACTIVATION
    • 8.4.1. SOLVENT DETERGENT METHOD
    • 8.4.2. PASTEURIZATION
    • 8.4.3. OTHER METHODS

9. VIRAL CLEARANCE MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
  • 9.4. ASIA
  • 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
    • 10.1.1. STRATEGIC OVERVIEW
  • 10.2. LEADING PLAYERS IN THE VIRAL CLEARANCE MARKET
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. EXPANSIONS
    • 10.3.2. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 10.3.3. ACQUISITIONS
    • 10.3.4. SERVICES LAUNCHES

11. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 11.1. INTRODUCTION
  • 11.2. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • 11.3. LONZA GROUP
  • 11.4. SIGMA-ALDRICH CORPORATION
  • 11.5. SGS S.A.
  • 11.6. WUXI PHARMATECH (CAYMAN) INC.
  • 11.7. AVANCE BIOSCIENCES INC.
  • 11.8. BSL BIOSERVICE
  • 11.9. CLEAN CELLS INC.
  • 11.10. MERCK KGAA
  • 11.11. TEXCELL, INC.

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. OTHER DEVELOPMENTS
  • 12.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.6. AVAILABLE CUSTOMIZATIONS
  • 12.7. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: VIRAL CLEARANCE MARKET SUMMARY
  • TABLE 2: RAPID GROWTH IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES DRIVING THE GROWTH OF THE VIRAL CLEARANCE MARKET
  • TABLE 3: HIGH DEGREE OF CONSOLIDATION IS A MAJOR MARKET RESTRAINT
  • TABLE 4: INCREASING PHARMACEUTICAL OUTSOURCING TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES IN THE VIRAL CLEARANCE MARKET
  • TABLE 5: STRINGENT REGULATORY FRAMEWORKS ARE A MAJOR MARKET CHALLENGE
  • TABLE 6: VIRAL CLEARANCE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 7: VIRAL CLEARANCE MARKET SIZE FOR VACCINES AND THERAPEUTICS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 8: VIRAL CLEARANCE MARKET SIZE FOR BLOOD AND BLOOD PRODUCTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 9: VIRAL CLEARANCE MARKET SIZE FOR CELLULAR AND GENE THERAPY PRODUCTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 10: VIRAL CLEARANCE MARKET SIZE FOR TISSUE AND TISSUE PRODUCTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 11: VIRAL CLEARANCE MARKET SIZE FOR STEM CELL PRODUCTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 12: VIRAL CLEARANCE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 13: VIRAL CLEARANCE MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: VIRAL CLEARANCE MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 15: VIRAL CLEARANCE MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: VIRAL CLEARANCE MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 17: VIRAL CLEARANCE MARKET SIZE, BY METHOD, 2013-2020 (USD MILLION)
  • TABLE 18: VIRAL CLEARANCE MARKET SIZE FOR VIRAL DETECTION, BY METHOD, 2013-2020 (USD MILLION)
  • TABLE 19: VIRAL CLEARANCE MARKET SIZE FOR VIRAL DETECTION, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 20: VIRAL DETECTION MARKET SIZE FOR PLAQUE ASSAYS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 21: VIRAL DETECTION MARKET SIZE FOR PCR, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 22: VIRAL DETECTION MARKET SIZE FOR ELISA, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 23: VIRAL DETECTION MARKET SIZE FOR OTHER METHODS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 24: VIRAL CLEARANCE MARKET SIZE FOR VIRAL REMOVAL, BY METHOD, 2013-2020 (USD MILLION)
  • TABLE 25: VIRAL CLEARANCE MARKET SIZE FOR VIRAL REMOVAL, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 26: VIRAL REMOVAL MARKET SIZE FOR CHROMATOGRAPHY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 27: VIRAL REMOVAL MARKET SIZE FOR NANOFILTRATION, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 28: VIRAL REMOVAL MARKET SIZE FOR PRECIPITATION, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: VIRAL CLEARANCE MARKET SIZE FOR VIRAL INACTIVATION, BY METHOD, 2013-2020 (USD MILLION)
  • TABLE 30: VIRAL CLEARANCE MARKET SIZE FOR VIRAL INACTIVATION, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 31: VIRAL INACTIVATION MARKET SIZE FOR SOLVENT DETERGENT METHOD, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 32: VIRAL INACTIVATION MARKET SIZE FOR PASTEURIZATION, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 33: VIRAL INACTIVATION MARKET SIZE FOR OTHER METHODS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 34: VIRAL CLEARANCE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 35: NORTH AMERICA: VIRAL CLEARANCE MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 36: NORTH AMERICA: VIRAL CLEARANCE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 37: NORTH AMERICA: VIRAL CLEARANCE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 38: NORTH AMERICA: VIRAL CLEARANCE MARKET SIZE, BY METHOD, 2013-2020 (USD MILLION)
  • TABLE 39: NORTH AMERICA: VIRAL DETECTION METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 40: NORTH AMERICA: VIRAL REMOVAL METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 41: NORTH AMERICA: VIRAL INACTIVATION METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 42: U.S.: VIRAL CLEARANCE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 43: U.S.: VIRAL CLEARANCE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 44: U.S.: VIRAL CLEARANCE MARKET SIZE, BY METHOD, 2013-2020 (USD MILLION)
  • TABLE 45: U.S.: VIRAL DETECTION METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 46: U.S.: VIRAL REMOVAL METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 47: U.S.: VIRAL INACTIVATION METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 48: CANADA: VIRAL CLEARANCE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 49: CANADA: VIRAL CLEARANCE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 50: CANADA: VIRAL CLEARANCE MARKET SIZE, BY METHOD, 2013-2020 (USD MILLION)
  • TABLE 51: CANADA: VIRAL DETECTION METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 52: CANADA: VIRAL REMOVAL METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 53: CANADA: VIRAL INACTIVATION METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 54: EUROPE: VIRAL CLEARANCE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 55: EUROPE: VIRAL CLEARANCE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 56: EUROPE: VIRAL CLEARANCE MARKET SIZE, BY METHOD, 2013-2020 (USD MILLION)
  • TABLE 57: EUROPE: VIRAL DETECTION METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 58: EUROPE: VIRAL REMOVAL METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 59: EUROPE: VIRAL INACTIVATION METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 60: ASIA: VIRAL CLEARANCE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 61: ASIA: VIRAL CLEARANCE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 62: ASIA: VIRAL CLEARANCE MARKET SIZE, BY METHOD, 2013-2020 (USD MILLION)
  • TABLE 63: ASIA: VIRAL DETECTION METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 64: ASIA: VIRAL REMOVAL METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 65: ASIA: VIRAL INACTIVATION METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 66: ROW: VIRAL CLEARANCE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 67: ROW: VIRAL CLEARANCE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 68: ROW: VIRAL CLEARANCE MARKET SIZE, BY METHOD, 2013-2020 (USD MILLION)
  • TABLE 69: ROW: VIRAL DETECTION METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 70: ROW: VIRAL REMOVAL METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 71: ROW: VIRAL INACTIVATION METHODS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 72: MARKET DEVELOPMENTS BETWEEN 2012 AND 2016
  • TABLE 73: EXPANSIONS, 2012-2016
  • TABLE 74: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2012-2016
  • TABLE 75: ACQUISITIONS, 2012-2016
  • TABLE 76: SERVICES LAUNCHES, 2012-2015

LIST OF FIGURES

  • FIGURE 1: GLOBAL VIRAL CLEARANCE MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: VIRAL CLEARANCE MARKET SIZE, BY APPLICATION, 2015 VS. 2020 (USD MILLION)
  • FIGURE 8: VIRAL CLEARANCE MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION)
  • FIGURE 9: VIRAL CLEARANCE MARKET SIZE, BY METHOD, 2015 VS. 2020 (USD MILLION)
  • FIGURE 10: VIRAL CLEARANCE MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION)
  • FIGURE 11: GROWTH IN THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES WILL DRIVE THE VIRAL CLEARANCE MARKET IN THE FORCASTED PERIOD (2015-2020)
  • FIGURE 12: VACCINES AND THERAPEUTICS APPLICATION SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015
  • FIGURE 13: ASIA TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD (2015 TO 2020)
  • FIGURE 14: ASIA HOLDS LUCRATIVE GROWTH OPPORTUNITIES
  • FIGURE 15: VIRAL CLEARANCE MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 16: VIRAL CLEARANCE MARKET SEGMENTATION, BY END USER
  • FIGURE 17: VIRAL CLEARANCE MARKET SEGMENTATION, BY METHOD
  • FIGURE 18: VIRAL CLEARANCE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 19: NUMBER OF NEW BIOLOGICS LAUNCHED, BY YEAR, 2003-2013
  • FIGURE 20: VIRAL CLEARANCE MARKET, BY APPLICATION
  • FIGURE 21: VIRAL CLEARANCE MARKET SIZE, BY APPLICATION, 2015 (USD MILLION)
  • FIGURE 22: NORTH AMERICA TO DOMINATE THE VACCINES AND THERAPEUTICS APPLICATION SEGMENT IN 2015
  • FIGURE 23: NORTH AMERICA TO DOMINATE THE BLOOD AND BLOOD PRODUCTS APPLICATION SEGMENT IN 2015
  • FIGURE 24: ASIA TO WITNESS HIGHEST GROWTH IN THE CELLULAR AND GENE THERAPY PRODUCTS APPLICATION SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 25: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE TISSUE AND TISSUE PRODUCTS APPLICATION SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 26: ASIA TO WITNESS HIGHEST GROWTH IN THE STEM CELL PRODUCTS APPLICATION SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 27: VIRAL CLEARANCE MARKET, BY END USER
  • FIGURE 28: VIRAL CLEARANCE MARKET SIZE, BY END USER, 2015 (USD MILLION)
  • FIGURE 29: NORTH AMERICA TO DOMINATE THE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES END-USER SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 30: ASIA TO WITNESS THE HIGHEST GROWTH IN THE CONTRACT RESEARCH ORGANIZATIONS END-USER SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 31: ASIA TO WITNESS THE HIGHEST GROWTH IN THE ACADEMIC RESEARCH INSTITUTES END-USER SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 32: NORTH AMERICA TO DOMINATE THE OTHER END-USERS SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 33: VIRAL CLEARANCE MARKET, BY METHOD
  • FIGURE 34: VIRAL CLEARANCE MARKET SIZE, BY METHOD, 2015 (USD MILLION)
  • FIGURE 35: PLAQUE ASSAYS TO DOMINATE THE VIRAL DETECTION METHOD SEGMENT IN 2015
  • FIGURE 36: NORTH AMERICA TO DOMINATE THE VIRAL DETECTION MARKET IN 2015
  • FIGURE 37: NORTH AMERICA TO DOMINATE THE PLAQUE ASSAYS METHOD SEGMENT IN 2015
  • FIGURE 38: NORTH AMERICA TO DOMINATE THE PCR MARKET IN 2015
  • FIGURE 39: NORTH AMERICA TO DOMINATE THE MARKET FOR ELISA METHOD IN 2015
  • FIGURE 40: NORTH AMERICA TO DOMINATE THE MARKET FOR OTHER VIRAL DETECTION METHODS IN 2015
  • FIGURE 41: CHROMATOGRAPHY TO DOMINATE THE VIRAL REMOVAL METHODS SEGMENT IN 2015
  • FIGURE 42: NORTH AMERICA TO DOMINATE THE VIRAL REMOVAL MARKET IN 2015
  • FIGURE 43: NORTH AMERICA TO DOMINATE THE CHROMATOGRAPHY MARKET IN 2015
  • FIGURE 44: NORTH AMERICA TO COMMAND LARGEST SHARE IN THE NANOFILTRATION SEGMENT IN 2015
  • FIGURE 45: NORTH AMERICA TO HOLD LARGEST SHARE OF THE PRECIPITATION MARKET IN 2015
  • FIGURE 46: SOLVENT DETERGENT METHOD TO HOLD LARGEST SHARE IN VIRAL INACTIVATION MARKET IN 2015
  • FIGURE 47: NORTH AMERICA TO DOMINATE THE VIRAL INACTIVATION MARKET IN 2015
  • FIGURE 48: NORTH AMERICA TO DOMINATE THE SOLVENT DETERGENT METHOD SEGMENT IN 2015
  • FIGURE 49: NORTH AMERICA TO DOMINATE THE PASTEURIZATION SEGMENT IN 2015
  • FIGURE 50: NORTH AMERICA TO DOMINATE THE OTHER VIRAL INACTIVATION METHODS SEGMENT IN 2015
  • FIGURE 51: VIRAL CLEARANCE MARKET SEGMENTATION, BY REGION
  • FIGURE 52: NORTH AMERICA TO DOMINATE THE GLOBAL VIRAL CLEARANCE MARKET DURING THE FORECAST PERIOD
  • FIGURE 53: ASIAN VIRAL CLEARANCE MARKET TO WITNESS THE HIGHEST GROWTH FROM 2015 TO 2020
  • FIGURE 54: NORTH AMERICA: VIRAL CLEARANCE MARKET SNAPSHOT
  • FIGURE 55: U.S. TO WITNESS HIGHEST GROWTH IN THE NORTH AMERICAN VIRAL CLEARANCE MARKET
  • FIGURE 56: VACCINES AND THERAPEUTICS SEGMENT TO COMMAND THE LARGEST SHARE OF THE NORTH AMERICAN VIRAL CLEARANCE MARKET
  • FIGURE 57: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DOMINATE THE NORTH AMERICAN VIRAL CLEARANCE MARKET, BY END USER
  • FIGURE 58: VIRAL DETECTION, THE LARGEST METHOD SEGMENT IN NORTH AMERICA IN 2015
  • FIGURE 59: PLAQUE ASSAYS SEGMENT TO HOLD LARGEST SHARE OF THE NORTH AMERICAN VIRAL DETECTION MARKET IN 2015
  • FIGURE 60: CHROMATOGRAPHY TO FORM THE LARGEST VIRAL REMOVAL METHOD SEGMENT IN NORTH AMERICA IN 2015
  • FIGURE 61: SOLVENT DETERGENT SEGMENT TO DOMINATE THE VIRAL INACTIVATION MARKET, BY METHOD, IN NORTH AMERICA
  • FIGURE 62: VACCINES AND THERAPEUTICS SEGMENT TO COMMAND THE LARGEST SHARE OF THE EUROPEAN VIRAL CLEARANCE MARKET
  • FIGURE 63: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DOMINATE THE EUROPEAN VIRAL CLEARANCE MARKET
  • FIGURE 64: VIRAL DETECTION TO DOMINATE THE VIRAL CLEARANCE METHODS MARKET IN EUROPE IN 2015
  • FIGURE 65: PLAQUE ASSAYS TO FORM THE LARGEST VIRAL DETECTION METHOD SEGMENT IN EUROPE IN 2015
  • FIGURE 66: CHROMATOGRAPHY TO FORM THE LARGEST VIRAL REMOVAL METHOD SEGMENT IN EUROPE IN 2015
  • FIGURE 67: SOLVENT DETERGENT METHOD TO FORM THE LARGEST VIRAL INACTIVATION METHOD SEGMENT IN EUROPE IN 2015
  • FIGURE 68: ASIA: VIRAL CLEARANCE MARKET SNAPSHOT
  • FIGURE 69: VACCINES AND THERAPEUTICS SEGMENT TO COMMAND THE LARGEST SHARE OF THE ASIAN VIRAL CLEARANCE MARKET
  • FIGURE 70: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DOMINATE THE ASIAN VIRAL CLEARANCE MARKET
  • FIGURE 71: VIRAL DETECTION TO DOMINATE THE VIRAL CLEARANCE METHODS MARKET IN ASIA IN 2015
  • FIGURE 72: PLAQUE ASSAYS TO FORM THE LARGEST VIRAL DETECTION METHOD SEGMENT IN ASIA IN 2015
  • FIGURE 73: CHROMATOGRAPHY TO FORM THE LARGEST VIRAL REMOVAL METHOD SEGMENT IN ASIA IN 2015
  • FIGURE 74: SOLVENT DETERGENT METHOD TO FORM THE LARGEST VIRAL INACTIVATION METHOD SEGMENT IN ASIA IN 2015
  • FIGURE 75: VACCINES AND THERAPEUTICS SEGMENT TO COMMAND THE LARGEST SHARE OF THE VIRAL CLEARANCE MARKET IN THE REST OF THE WORLD REGION
  • FIGURE 76: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRAL CLEARANCE MARKET IN THE REST OF THE WORLD REGION
  • FIGURE 77: VIRAL DETECTION TO DOMINATE THE VIRAL CLEARANCE METHODS MARKET IN THE REST OF THE WORLD REGION IN 2015
  • FIGURE 78: PLAQUE ASSAYS TO FORM THE LARGEST VIRAL DETECTION METHOD SEGMENT IN THE REST OF THE WORLD REGION IN 2015
  • FIGURE 79: CHROMATOGRAPHY TO FORM THE LARGEST VIRAL REMOVAL METHOD SEGMENT IN THE REST OF THE WORLD REGION IN 2015
  • FIGURE 80: SOLVENT DETERGENT METHOD TO FORM THE LARGEST VIRAL INACTIVATION METHOD SEGMENT IN THE REST OF THE WORLD REGION IN 2015
  • FIGURE 81: EXPANSIONS AND ACQUISITIONS-KEY STRATEGIES ADOPTED BY PLAYERS
  • FIGURE 82: VIRAL CLEARANCE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 83: FINANCIAL PERFORMANCE OF LEADING MARKET PLAYERS
  • FIGURE 84: COMPANY SNAPSHOT: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • FIGURE 85: COMPANY SNAPSHOT: LONZA GROUP
  • FIGURE 86: COMPANY SNAPSHOT: SIGMA-ALDRICH CORPORATION
  • FIGURE 87: COMPANY SNAPSHOT: SGS S.A.
  • FIGURE 88: COMPANY SNAPSHOT: WUXI PHARMATECH (CAYMAN) INC.
  • FIGURE 89: COMPANY SNAPSHOT: MERCK & CO., INC.
Back to Top